S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court

Pacira BioSciences (PCRX) News Today

$26.83
-0.53 (-1.94%)
(As of 04/12/2024 ET)
SourceHeadline
finance.yahoo.com logoPacira BioSciences (NASDAQ:PCRX) stock falls 4.1% in past week as three-year earnings and shareholder returns continue downward trend
finance.yahoo.com - April 11 at 9:46 AM
marketbeat.com logoBaillie Gifford & Co. Sells 573,810 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)
marketbeat.com - April 11 at 7:23 AM
MarketBeat logoPacira BioSciences (NASDAQ:PCRX) Given Buy Rating at Needham & Company LLC
americanbankingnews.com - April 10 at 4:16 AM
markets.businessinsider.com logoUnderstanding Key Factors Behind Pacira Pharmaceuticals’ Analyst Rating
markets.businessinsider.com - April 9 at 2:43 PM
marketbeat.com logoPacira BioSciences (NASDAQ:PCRX) Given "Buy" Rating at Needham & Company LLC
marketbeat.com - April 9 at 8:30 AM
nasdaq.com logoCommit To Purchase Pacira BioSciences At $15, Earn 12.5% Annualized Using Options
nasdaq.com - April 6 at 9:01 AM
globenewswire.com logoPacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
globenewswire.com - April 2 at 8:00 AM
marketbeat.com logoPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Acquired by Assenagon Asset Management S.A.
marketbeat.com - March 30 at 4:51 AM
marketbeat.com logoGradient Investments LLC Increases Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)
marketbeat.com - March 29 at 3:45 PM
marketbeat.com logoTributary Capital Management LLC Raises Stock Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)
marketbeat.com - March 26 at 9:48 AM
marketbeat.com logoWellington Management Group LLP Lowers Stake in Pacira BioSciences, Inc. (NASDAQ:PCRX)
marketbeat.com - March 25 at 4:09 AM
marketbeat.com logoDeutsche Bank AG Has $5.60 Million Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)
marketbeat.com - March 22 at 4:16 AM
insidertrades.com logoGary W. Pace Sells 1,066 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) Stock
insidertrades.com - March 18 at 6:46 AM
finance.yahoo.com logoPCRX Apr 2024 22.500 put
finance.yahoo.com - March 16 at 8:44 AM
marketwatch.com logoPacira's PCRX-201 Gets FDA RMAT Designation in Knee Osteoarthritis
marketwatch.com - March 13 at 8:55 PM
markets.businessinsider.com logoPacira BioSciences Receives RMAT Designation For Gene Therapy Product Candidate In Osteoarthritis
markets.businessinsider.com - March 13 at 10:37 AM
globenewswire.com logoPacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee
globenewswire.com - March 13 at 7:00 AM
insidertrades.com logoPacira BioSciences, Inc. (NASDAQ:PCRX) Director Sells $2,754,000.00 in Stock
insidertrades.com - March 11 at 5:35 AM
marketbeat.com logoSchroder Investment Management Group Cuts Stake in Pacira BioSciences, Inc. (NASDAQ:PCRX)
marketbeat.com - March 10 at 7:23 AM
finance.yahoo.com logoDirector Gary Pace Sells 119,323 Shares of Pacira BioSciences Inc (PCRX)
finance.yahoo.com - March 9 at 7:05 AM
marketbeat.com logoInsider Selling: Pacira BioSciences, Inc. (NASDAQ:PCRX) Director Sells 1,066 Shares of Stock
marketbeat.com - March 8 at 7:44 PM
marketbeat.com logoJPMorgan Chase & Co. Reiterates Overweight Rating for Pacira BioSciences (NASDAQ:PCRX)
marketbeat.com - March 7 at 8:21 AM
marketbeat.com logoHC Wainwright Comments on Pacira BioSciences, Inc.'s FY2025 Earnings (NASDAQ:PCRX)
marketbeat.com - March 7 at 7:53 AM
globenewswire.com logoPacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Conference
globenewswire.com - March 6 at 8:00 AM
marketbeat.com logoQ1 2024 EPS Estimates for Pacira BioSciences, Inc. (NASDAQ:PCRX) Reduced by HC Wainwright
marketbeat.com - March 6 at 7:31 AM
marketbeat.com logoGlenmede Trust Co. NA Has $10.65 Million Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)
marketbeat.com - March 5 at 10:56 AM
markets.businessinsider.com logoBuy Rating for Pacira Pharmaceuticals Amid Strong Growth Prospects and Robust IP Protection
markets.businessinsider.com - March 4 at 2:19 PM
marketbeat.com logoPacira BioSciences (NASDAQ:PCRX) Earns "Buy" Rating from HC Wainwright
marketbeat.com - March 4 at 8:25 AM
markets.businessinsider.com logoBuy Rating Affirmed for Pacira Pharmaceuticals Amid Strategic Growth Initiatives and Management Restructuring
markets.businessinsider.com - March 3 at 3:48 PM
markets.businessinsider.com logoNavigating 4 Analyst Ratings For Pacira BioSciences
markets.businessinsider.com - March 1 at 11:50 AM
finance.yahoo.com logoPacira BioSciences Full Year 2023 Earnings: EPS Beats Expectations
finance.yahoo.com - March 1 at 11:50 AM
finance.yahoo.com logoPacira BioSciences, Inc. (NASDAQ:PCRX) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 1 at 11:50 AM
marketbeat.com logoPacira BioSciences (NASDAQ:PCRX) Price Target Cut to $45.00 by Analysts at Royal Bank of Canada
marketbeat.com - March 1 at 11:21 AM
markets.businessinsider.com logoStrong Buy Rating for Pacira Pharmaceuticals Amid Favorable NOPAIN Act Implications and Strategic Growth Initiatives
markets.businessinsider.com - March 1 at 6:49 AM
finance.yahoo.com logoQ4 2023 Pacira Biosciences Inc Earnings Call
finance.yahoo.com - March 1 at 6:49 AM
msn.com logoPacira BioSciences GAAP EPS of $0.54 beats by $0.15, revenue of $181.2M beats by $0.34M
msn.com - February 29 at 12:44 PM
finance.yahoo.com logoPacira BioSciences Inc (PCRX) Reports Record Revenues and Robust Earnings for Full-Year 2023
finance.yahoo.com - February 29 at 12:44 PM
globenewswire.com logoPacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results
globenewswire.com - February 29 at 8:00 AM
benzinga.com logoPreview: Pacira BioSciences's Earnings
benzinga.com - February 28 at 4:29 PM
msn.com logoPacira BioSciences Q4 2023 Earnings Preview
msn.com - February 28 at 4:29 PM
marketbeat.com logoFederated Hermes Inc. Cuts Stock Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)
marketbeat.com - February 27 at 6:45 AM
marketbeat.com logoEagle Asset Management Inc. Acquires 62,597 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)
marketbeat.com - February 26 at 7:57 AM
marketbeat.com logoPacira BioSciences (PCRX) to Release Earnings on Thursday
marketbeat.com - February 23 at 9:50 AM
marketbeat.com logoPacira BioSciences, Inc. to Post Q3 2024 Earnings of $0.59 Per Share, Zacks Research Forecasts (NASDAQ:PCRX)
marketbeat.com - February 23 at 7:33 AM
marketbeat.com logoDeutsche Bank AG Decreases Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)
marketbeat.com - February 23 at 5:15 AM
finance.yahoo.com logoPacira to Report 2023 Financial Results on Thursday February 29, 2024
finance.yahoo.com - February 22 at 8:26 AM
globenewswire.com logoPacira to Report 2023 Financial Results on Thursday February 29, 2024
globenewswire.com - February 22 at 8:00 AM
marketbeat.com logoPacira BioSciences, Inc. Expected to Earn Q1 2024 Earnings of $0.53 Per Share (NASDAQ:PCRX)
marketbeat.com - February 22 at 6:50 AM
marketbeat.com logoPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Commonwealth of Pennsylvania Public School Empls Retrmt SYS
marketbeat.com - February 21 at 5:35 AM
finance.yahoo.com logoPCRX Mar 2024 32.500 put
finance.yahoo.com - February 18 at 6:43 PM
Get Pacira BioSciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for PCRX and its competitors with MarketBeat's FREE daily newsletter.

The Next Bitcoin Millionaires (Ad)

100,000 people became millionaires during Bitcoin’s last bull market. If you missed out… You have a second chance.

This is what the smart money is buying...

PCRX Media Mentions By Week

PCRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PCRX
News Sentiment

0.50

0.65

Average
Medical
News Sentiment

PCRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PCRX Articles
This Week

7

3

PCRX Articles
Average Week

Get Pacira BioSciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for PCRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:PCRX) was last updated on 4/14/2024 by MarketBeat.com Staff

From Our Partners